Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care.

Pharmaceuticals 167

Pharmaceuticals Drug Development Digital Health 167

Lloyd Price

NOVEMBER 8, 2024

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Interoperability 72

Interoperability healthcare technology HIPAA Leadership 72

Lloyd Price

DECEMBER 2, 2024

Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. This shift towards digitalisation is improving patient outcomes and reducing healthcare costs.

Digital Health 56

Digital Health healthcare technology Telemedicine Leadership 56

Digital Health Global

JANUARY 4, 2024

Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.

Health Technology 88

Health Technology Digital Health Drug Development healthcare technology 88

Lloyd Price

JANUARY 20, 2025

In the context of healthtech and digital health, it means a company initially targets consumers (B2C), builds a strong user base, and then leverages this consumer adoption to attract businesses (B2B), such as insurers, employers, or healthcare providers. Exec Summary: B2C2B stands for Business-to-Consumer-to-Business. Subscribe Today!

Mental health 60

Mental health healthcare technology Telehealth Digital Health 60

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health 52

Digital Health Drug Development Pharmaceuticals Nursing 52

Redox

SEPTEMBER 26, 2023

Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. Don’t get so immersed in system processing that you overlook data quality and accessibility, says Deloitte’s Cloud Strategy Officer.

FHIR 105

FHIR Drug Development Telehealth Digital Health 105

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health 80

Digital Health Drug Development Telemedicine Telehealth 80

Digital Health Global

APRIL 25, 2024

This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Lloyd Price

JULY 15, 2024

Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Artificial intelligence: This is a rapidly developing field that has the potential to revolutionize healthcare. Subscribe Today!

Digital Health 60

Digital Health Mobile Health Telehealth Mental health 60

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 105

Life Science Drug Development Digital Health Health IT 105

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. Cees Wortel, Ph.D., After earning his M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Digital Health Global

MAY 29, 2024

“Masimo’s SET ® pulse oximetry is sensitive enough to capture key vitals on the very ill like cancer patients, plus it works on all skin tones, all ages, and is easy to use,” said Musaddiq Khan, Medable’s Vice President of Digital Outcomes and TA Strategy. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Drug Development 88

Drug Development Digital Health 88

Lloyd Price

SEPTEMBER 16, 2024

Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!

Digital Health 63

Digital Health Drug Development healthcare technology Leadership 63

Lloyd Price

AUGUST 3, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Mental health 69

Mental health Pain management Drug Development Leadership 69

Digital Health Global

JUNE 2, 2024

This collaboration not only addresses the immediate needs of patients but also bridges critical gaps in mental and physical health care during their treatment journey.”

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88

Lloyd Price

NOVEMBER 21, 2023

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development 69

Drug Development Health science healthcare technology Leadership 69

Lloyd Price

MAY 30, 2024

As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to develop strategy and implementation, effectively communicate the benefits and risks of AI to all stakeholders and oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulation.

Leadership 72

Leadership healthcare technology Interoperability Drug Development 72

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa.

healthcare technology 72

healthcare technology Leadership Drug Development Digital Health 72

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

healthcare technology 72

healthcare technology Drug Development Leadership Digital Health 72

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Lloyd Price

OCTOBER 9, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Mental health 60

Mental health healthcare technology Leadership Digital Health 60

Lloyd Price

AUGUST 7, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Interoperability 60

Interoperability Leadership Drug Development EHR 60

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals 63

Pharmaceuticals healthcare technology Digital Health Remote care 63

Lloyd Price

MAY 6, 2024

Healthcare AI can adopt similar strategies to integrate and analyse diverse patient data, including medical records, environmental factors, genetic data, and sensor data from wearables. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

healthcare technology 69

healthcare technology Leadership Drug Development Digital Health 69

Lloyd Price

APRIL 22, 2024

Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 63

Pharmaceuticals Digital Health Drug Development Life Science 63

Lloyd Price

SEPTEMBER 6, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Leadership 74

Leadership Drug Development healthcare technology Digital Health 74

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Lloyd Price

FEBRUARY 22, 2024

Technological advancements: New technologies offer more personalised, data-driven, and effective pain management strategies. Tech-driven Solutions: Digital Therapeutics (DTx): App-based solutions offering personalized pain management programs, education, and support. The global pain management market is expected to reach $3.3

Pain management 56

Pain management Mental health Telehealth healthcare technology 56

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 63

Health Data Interoperability healthcare technology Leadership 63